Medications

Novartis insists its flu vaccines are safe

Swiss pharmaceutical giant Novartis insisted early Thursday that its flu vaccines were safe despite a sales ban by Italy, Switzerland and Austria.

Medications

Novartis chief sees sales dip until mid-2013

Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.

Diseases, Conditions, Syndromes

Controversial Down's syndrome testing gets Swiss go-ahead

Switzerland has given the green light for a new prenatal test for Down's syndrome amid controversy over whether this will lead to more abortions, a Swiss newspaper reported Sunday.

Oncology & Cancer

Researchers descover melanoma-promoting gene

Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich ...

Oncology & Cancer

EU approves skin cancer fighting drug: Roche

Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.

Other

Novartis announces 2,000 job losses, profits up

Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.

page 9 from 10